AOBiome Therapeutics, Inc.

📍 Cambridge, United States🗓 Founded 2013👥 14 employees💰 Last funded Aug 2012
Biotechnology🌐 aobiome.com
Website LinkedIn
AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in AOBiome Therapeutics, Inc.?
AOBiome Therapeutics, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did AOBiome Therapeutics, Inc. last raise funding?
The most recent investment in AOBiome Therapeutics, Inc. recorded on gritt.io was in August 2012.
When was AOBiome Therapeutics, Inc. founded?
AOBiome Therapeutics, Inc. was founded in 2013.
What industry is AOBiome Therapeutics, Inc. in?
AOBiome Therapeutics, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is AOBiome Therapeutics, Inc. based?
AOBiome Therapeutics, Inc. is headquartered in Cambridge, United States.